These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4790046)

  • 21. [Cholesterol metabolism and plasma lecithin-cholesterol acyl transferase in experimental hepatitis and cholestasis in the rat].
    Kattermann R; Wolfrum DI
    Z Klin Chem Klin Biochem; 1970 Jul; 8(4):413-9. PubMed ID: 5450086
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes in the fatty acid composition of lipids from the liver and hepatic microsomes of rats with carbon tetrachloride poisoning].
    Comporti M; Burdino E; Ugazio G
    Boll Soc Ital Biol Sper; 1969 May; 45(10):700-3. PubMed ID: 5399990
    [No Abstract]   [Full Text] [Related]  

  • 23. Fatty acid composition of phospholipids in mitochondria and microsomes during diethylnitrosamine carcinogenesis in rat liver.
    Canuto RA; Biocca ME; Muzio G; Dianzani MU
    Cell Biochem Funct; 1989 Jan; 7(1):11-9. PubMed ID: 2752533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of endotoxins in renal changes during hepatopathies].
    Liehr H; Grün M
    Minerva Med; 1978 Oct; 69(47):3231-42. PubMed ID: 362247
    [No Abstract]   [Full Text] [Related]  

  • 25. [Changes in the phospholipid content of liver microsomes following various pretreatments of rats and guinea pigs].
    Schulze HU; Staudinger H
    Hoppe Seylers Z Physiol Chem; 1970 Feb; 351(2):184-93. PubMed ID: 4313837
    [No Abstract]   [Full Text] [Related]  

  • 26. D-galactosamine and acute liver cell injury.
    Shinozuka H; Farber JL; Konishi Y; Anukarahanonta T
    Fed Proc; 1973 Apr; 32(4):1516-26. PubMed ID: 4701754
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of experimental cholestasis on the negative feedback regulation of cholesterol synthesis in rat liver.
    Kattermann R; Creutzfeldt W
    Scand J Gastroenterol; 1970; 5(5):337-42. PubMed ID: 5455818
    [No Abstract]   [Full Text] [Related]  

  • 28. Phospholipids in endoplasmic reticulum - their relationship to drug metabolism in experimental liver disease.
    Gallenkamp H
    Acta Hepatogastroenterol (Stuttg); 1977 Oct; 24(5):309-16. PubMed ID: 930533
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug disposition and liver disease.
    Wilkinson GR; Schenker S
    Drug Metab Rev; 1975; 4(2):139-75. PubMed ID: 770104
    [No Abstract]   [Full Text] [Related]  

  • 30. [Chemical structure of the endoplasmic reticulum and function of the microsomal biotransformation system of liver cells in experimental cholestasis in the rat].
    Denk H
    Pathol Eur; 1972; 7(1):43-65. PubMed ID: 5054568
    [No Abstract]   [Full Text] [Related]  

  • 31. [Animal disease models--injury, death and various changes of liver cells].
    Taoka Y
    Nihon Rinsho; 1985 Jun; 43(6):1239-50. PubMed ID: 3900478
    [No Abstract]   [Full Text] [Related]  

  • 32. [Significance of enzyme activity in pyrimidine biosynthesis for the development of galactosamine liver lesions].
    Pausch J; Keppler D; Decker K
    Verh Dtsch Ges Inn Med; 1972; 78():1375-7. PubMed ID: 4665550
    [No Abstract]   [Full Text] [Related]  

  • 33. Histochemical and enzymatic studies on bilirubin metabolism in experimental and clinical liver disorders.
    Kanie F
    Nagoya Med J; 1972 Feb; 17(3):123-44. PubMed ID: 5050755
    [No Abstract]   [Full Text] [Related]  

  • 34. [Incorporation of 14-C-Glycine during galactosamine hepatitis of young and old rats (author's transl)a*].
    Platt D; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jul; 6(7):319-27. PubMed ID: 14537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Status of the antioxidant, monooxygenase and humoral immune system of the body in d-galactosamine hepatitis].
    Korda MM
    Ukr Biokhim Zh (1978); 1996; 68(1):72-5. PubMed ID: 8755105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Liver damages and lipid metabolism. II. Biosynthesis of cholesterol, phospholipids and glycerides in the liver in experimental cholestasis in the rat].
    Kattermann R; Reimold WV
    Acta Hepatosplenol; 1970; 17(2):75-84. PubMed ID: 5524292
    [No Abstract]   [Full Text] [Related]  

  • 37. Lipoprotein abnormalities in galactosamine hepatitis: a model of experimental lecithin:cholesterol acyltransferase deficiency.
    Sabesin SM; Kuiken LB; Ragland JB
    Scand J Clin Lab Invest Suppl; 1978; 150():187-93. PubMed ID: 746347
    [No Abstract]   [Full Text] [Related]  

  • 38. [Behavior of 125-I-fibrinogen and 131-I-albumin in experimental galactosamine hepatitis].
    von Mahn I; Merkel H; Sattler EL; Müller-Berghaus G
    Verh Dtsch Ges Inn Med; 1974; 80():437-9. PubMed ID: 4454578
    [No Abstract]   [Full Text] [Related]  

  • 39. [Studies on the mechanism of galactosamine-induced hepatitis].
    Keppler D; Reutter W; Lesch R; Decker K
    Verh Dtsch Ges Inn Med; 1969; 75():361-3. PubMed ID: 5400153
    [No Abstract]   [Full Text] [Related]  

  • 40. [Alteration of the lipid composition of rat liver microsomes on reconstitution of the cytochrom P-450 system. Inactivation of the enzyme by lysolecithin].
    Diatlovitskaia EV; Lemenovskaia AF; Archakov AI; Khaitina SV; Bergel'son LD
    Biokhimiia; 1977 Jan; 42(1):139-43. PubMed ID: 851550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.